Current Edition

Peli BioThermal to Share Industry Insight at LogiPharma Europe

Announcement of European expansion for growing rental program
Peli BioThermal, the global name in temperature controlled packaging, will showcase its latest shipper solutions and announce its European expansion at LogiPharma Europe, being held in Montreux, Switzerland on April 10 – 12, 2018.
At the conference Peli BioThermal will reveal the latest developments of its expanding Cr?do™ on Demand rental program, which includes the launch of multiple new European drop points for end of rental drop-off of their passive temperature controlled containers (including Cr?do™ Cargo and Cr?do™ Xtreme).
Paul Terry, Peli BioThermal’s Director of Sales EMEA, said: “We are delighted to be exhibiting at LogiPharma where we will be announcing details of our European expansion alongside sharing our knowledge and extensive experience at this leading supply chain conference.”
Experts from the Peli BioThermal team, who will be exhibiting a range of reliable temperature controlled packaging, including its award-winning Chronos™ Advance, Chronos™ Express and Cr?do™ Cube shippers, will share industry insight and advice during the three-day event.
Peli BioThermal’s product portfolio being exhibited at the conference demonstrates the delivery of differing duration and performance capabilities to mitigate temperature excursions in the worldwide transportation of pharmaceutical products.
Industry issues including creating customer centric, demand driven, lower complexity supply chains and managing change for future security, traceability and serialisation for pharma will be addressed by industry leaders and delegates at the conference.

Visit the Peli BioThermal exhibition at stand 18 LogiPharma Europe or visit to learn more about the wide range of PeliBioThermal products and offerings.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.